BEROTEC

This brand name is authorized in Austria, Brazil, Germany, Estonia, Japan, Lithuania, Poland, South Africa

Active ingredients

The drug BEROTEC contains one active pharmaceutical ingredient (API):

1 Fenoterol UNII RLI45Z99RB - FENOTEROL HYDROBROMIDE

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
BEROTEC Inhaler	Health Products Regulatory Authority (ZA)	MPI, Generic

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
R03AC04	Fenoterol	R Respiratory system → R03 Drugs for obstructive airway diseases → R03A Adrenergics, inhalants → R03AC Selective beta-2-adrenoreceptor agonists
Discover more medicines within R03AC04

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 504500605135314, 504500606174313
Country: DE	Bundesinstitut für Arzneimittel und Medizinprodukte	Identifier(s): 00495906, 00495912
Country: EE	Ravimiamet	Identifier(s): 1044223
Country: JP	医薬品医療機器総合機構	Identifier(s): 2252704G2020
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1003787, 1069325, 1070362
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100009713, 100333201
Country: ZA	Health Products Regulatory Authority	Identifier(s): 34/10.2.1/0367